Stephan Schmidt Thomas Schulten
10.1177/1756286419846818
Ther Adv Neurol Disord
2019 May 6;12:1756286419846818.
disease-modifying therapy fingolimod multiple sclerosis ocrelizumab rebound
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/31105771/
Case Reports
PMC6503590
31105771
Severe rebound after cessation of fingolimod treated with ocrelizumab with coincidental transient aggravation: report of two cases
2019